DEVELOPMENT OF A HIGH-THROUGHPUT PROCESS FOR THE PRODUCTION OF DIAGNOSTIC MONOCLONAL ANTIBODIES (Q2035396): Difference between revisions

From EU Knowledge Graph
Jump to navigation Jump to search
(BatchIngestion)
(‎Changed label, description and/or aliases in pt)
 
(3 intermediate revisions by 2 users not shown)
label / ptlabel / pt
DESENVOLVIMENTO DE UM PROCESSO DE ALTO RENDIMENTO PARA A PRODUÇÃO DE ANTICORPOS MONOCLONAIS DE DIAGNÓSTICO
DESENVOLVIMENTO DE UM PROCESSO DE RECUPERAÇÃO ELEVADA PARA A PRODUÇÃO DE ANTIPOS MONOCLONAIS DIAGNÓSTICOS
Property / contained in Local Administrative Unit
 
Property / contained in Local Administrative Unit: Roma / rank
Normal rank
 
Property / summary: THE BIOTECH COMPANY IS INNOVATIVE AND EFFECTIVE MONOCLONAL ANTIBODIES FOR OWN ACCOUNT AND FOR HIRE OR REWARD. ALTHOUGH HIGHLY COMPETITIVE IN VACCINATION PROTOCOLS, THE CURRENT PROCESS LACKS A ROBOTIC SYSTEM FOR (English) / qualifier
 
readability score: 0.216222390671636
Amount0.216222390671636
Unit1
Property / summaryProperty / summary
A EMPRESA DE BIOTECNOLOGIA É ANTICORPOS MONOCLONAIS INOVADORES E EFICAZES POR CONTA PRÓPRIA E POR CONTA DE OUTREM. EMBORA ALTAMENTE COMPETITIVO EM PROTOCOLOS DE VACINAÇÃO, O PROCESSO ATUAL CARECE DE UM SISTEMA ROBÓTICO PARA (Portuguese)
A sociedade BIOTECH é uma sociedade monoclonal inovadora e eficaz por conta própria e por arrendamento ou compensação. Embora altamente competitivo nos protocolos de vacinação, o processo actual carece de um sistema robótico para (Portuguese)
Property / contained in Local Administrative Unit
 
Property / contained in Local Administrative Unit: Roma / rank
 
Normal rank

Latest revision as of 19:29, 8 October 2024

Project Q2035396 in Italy
Language Label Description Also known as
English
DEVELOPMENT OF A HIGH-THROUGHPUT PROCESS FOR THE PRODUCTION OF DIAGNOSTIC MONOCLONAL ANTIBODIES
Project Q2035396 in Italy

    Statements

    country
    Italy
    0 references
    EU contribution
    5,354.02 Euro
    0 references
    budget
    10,708.04 Euro
    0 references
    co-financing rate
    50.0 percent
    0 references
    start time
    23 February 2017
    0 references
    end time
    31 May 2019
    0 references
    expected end time
    3 December 2018
    0 references
    beneficiary name (string)
    TAKIS SRL
    0 references
    beneficiary
    Q277533
    0 references
    programme
    Lazio - ERDF
    0 references
    coordinate location

    41°53'35.95"N, 12°28'58.55"E
    0 references
    summary
    L'AZIENDA DI BIOTECNOLOGIE TAKIS PRODUCE IN MODO INNOVATIVO ED EFFICACE ANTICORPI MONOCLONALI PER CONTO PROPRIO E PER CONTO TERZI. SEBBENE MOLTO COMPETITIVA NEI PROTOCOLLI DI VACCINAZIONE, IL PROCESSO ATTUALE MANCA DI UN SISTEMA ROBOTIZZATO PER L (Italian)
    0 references
    THE BIOTECH COMPANY IS INNOVATIVE AND EFFECTIVE MONOCLONAL ANTIBODIES FOR OWN ACCOUNT AND FOR HIRE OR REWARD. ALTHOUGH HIGHLY COMPETITIVE IN VACCINATION PROTOCOLS, THE CURRENT PROCESS LACKS A ROBOTIC SYSTEM FOR (English)
    readability score
    0.216222390671636
    0 references
    LA SOCIÉTÉ DE BIOTECHNOLOGIE TAKIS PRODUIT DES ANTICORPS MONOCLONAUX INNOVANTS ET EFFICACES POUR SON PROPRE COMPTE ET POUR LE COMPTE DE TIERS. BIEN QUE TRÈS COMPÉTITIF DANS LES PROTOCOLES DE VACCINATION, LE PROCESSUS ACTUEL NE DISPOSE PAS D’UN SYSTÈME ROBOTISÉ POUR (French)
    point in time
    16 December 2021
    0 references
    TAKIS BIOTECHNOLOGIE BEDRIJF PRODUCEERT INNOVATIEVE EN EFFECTIEVE MONOKLONALE ANTILICHAMEN OP EIGEN EN VOOR REKENING VAN DERDEN. HOEWEL ZEER CONCURREREND IN VACCINATIEPROTOCOLLEN, ONTBREEKT HET HUIDIGE PROCES AAN EEN GEROBOTISEERD SYSTEEM VOOR (Dutch)
    point in time
    23 December 2021
    0 references
    TAKIS BIOTECHNOLOGIE-UNTERNEHMEN PRODUZIERT INNOVATIVE UND EFFEKTIVE MONOKLONALE ANTIKÖRPER FÜR SICH ALLEIN UND IM AUFTRAG DRITTER. OBWOHL IN DEN IMPFPROTOKOLLEN SEHR KONKURRENZFÄHIG IST, FEHLT DEM DERZEITIGEN PROZESS EIN ROBOTERSYSTEM FÜR (German)
    point in time
    24 December 2021
    0 references
    LA EMPRESA BIOTECNOLÓGICA TAKIS PRODUCE ANTICUERPOS MONOCLONALES INNOVADORES Y EFICACES POR SÍ SOLOS Y EN NOMBRE DE TERCEROS. AUNQUE MUY COMPETITIVO EN LOS PROTOCOLOS DE VACUNACIÓN, EL PROCESO ACTUAL CARECE DE UN SISTEMA ROBOTIZADO PARA (Spanish)
    point in time
    25 January 2022
    0 references
    BIOTEKVIRKSOMHEDEN ER INNOVATIVE OG EFFEKTIVE MONOKLONALE ANTISTOFFER FOR EGEN REGNING OG FOR FREMMED REGNING. SELV OM VACCINATIONSPROTOKOLLERNE ER MEGET KONKURRENCEDYGTIGE, MANGLER DEN NUVÆRENDE PROCES ET ROBOTSYSTEM TIL (Danish)
    point in time
    5 July 2022
    0 references
    Η ΕΤΑΙΡΕΊΑ ΒΙΟΤΕΧΝΟΛΟΓΊΑΣ ΕΊΝΑΙ ΚΑΙΝΟΤΌΜΑ ΚΑΙ ΑΠΟΤΕΛΕΣΜΑΤΙΚΆ ΜΟΝΟΚΛΩΝΙΚΆ ΑΝΤΙΣΏΜΑΤΑ ΓΙΑ ΊΔΙΟ ΛΟΓΑΡΙΑΣΜΌ ΚΑΙ ΓΙΑ ΛΟΓΑΡΙΑΣΜΌ ΤΡΊΤΟΥ Ή ΑΝΤΑΜΟΙΒΉΣ. ΑΝ ΚΑΙ ΙΔΙΑΊΤΕΡΑ ΑΝΤΑΓΩΝΙΣΤΙΚΉ ΣΤΑ ΠΡΩΤΌΚΟΛΛΑ ΕΜΒΟΛΙΑΣΜΟΎ, Η ΤΡΈΧΟΥΣΑ ΔΙΑΔΙΚΑΣΊΑ ΣΤΕΡΕΊΤΑΙ ΕΝΌΣ ΡΟΜΠΟΤΙΚΟΎ ΣΥΣΤΉΜΑΤΟΣ ΓΙΑ (Greek)
    point in time
    5 July 2022
    0 references
    BIOTEHNOLOŠKA TVRTKA JE INOVATIVNA I UČINKOVITA MONOKLONSKA ANTITIJELA ZA VLASTITI RAČUN I ZA NAJAM ILI NAKNADU. IAKO JE U PROTOKOLIMA CIJEPLJENJA VRLO KONKURENTAN, TRENUTAČNOM PROCESU NEDOSTAJE ROBOTSKI SUSTAV ZA (Croatian)
    point in time
    5 July 2022
    0 references
    COMPANIA BIOTEHNOLOGICĂ ESTE ANTICORPI MONOCLONALI INOVATORI ȘI EFICIENȚI ÎN NUME PROPRIU ȘI ÎN NUMELE UNUI TERȚ. DEȘI ESTE EXTREM DE COMPETITIV ÎN CEEA CE PRIVEȘTE PROTOCOALELE DE VACCINARE, PROCESUL ACTUAL NU DISPUNE DE UN SISTEM ROBOTIC PENTRU (Romanian)
    point in time
    5 July 2022
    0 references
    BIOTECHNOLOGICKÁ SPOLOČNOSŤ JE INOVATÍVNE A ÚČINNÉ MONOKLONÁLNE PROTILÁTKY NA VLASTNÝ ÚČET A NA PRENÁJOM ALEBO ODMENU. NAPRIEK VYSOKEJ KONKURENCIESCHOPNOSTI VAKCINAČNÝCH PROTOKOLOV SÚČASNÉMU PROCESU CHÝBA ROBOTICKÝ SYSTÉM PRE (Slovak)
    point in time
    5 July 2022
    0 references
    IL-KUMPANIJA BIJOTEKNOLOĠIKA HIJA ANTIKORPI MONOKLONALI INNOVATTIVI U EFFETTIVI GĦALL-KONT PROPRJU U GĦALL-KIRI JEW KUMPENS. GĦALKEMM KOMPETITTIV ĦAFNA FIL-PROTOKOLLI TAT-TILQIM, IL-PROĊESS ATTWALI HUWA NIEQES MINN SISTEMA ROBOTIKA GĦALL— (Maltese)
    point in time
    5 July 2022
    0 references
    A sociedade BIOTECH é uma sociedade monoclonal inovadora e eficaz por conta própria e por arrendamento ou compensação. Embora altamente competitivo nos protocolos de vacinação, o processo actual carece de um sistema robótico para (Portuguese)
    point in time
    5 July 2022
    0 references
    BIOTEKNIIKKAYRITYS ON INNOVATIIVISIA JA TEHOKKAITA MONOKLONAALISIA VASTA-AINEITA OMAAN KÄYTTÖÖN JA TOISTEN LUKUUN. VAIKKA ROKOTUSPROTOKOLLIT OVAT ERITTÄIN KILPAILUKYKYISIÄ, NYKYISELLÄ PROSESSILLA EI OLE ROBOTTIJÄRJESTELMÄÄ (Finnish)
    point in time
    5 July 2022
    0 references
    FIRMA BIOTECHNOLOGICZNA JEST INNOWACYJNYM I SKUTECZNYM PRZECIWCIAŁAMI MONOKLONALNYMI NA WŁASNY RACHUNEK I ZA WYNAGRODZENIEM. POMIMO WYSOKIEJ KONKURENCYJNOŚCI W PROTOKOŁACH SZCZEPIEŃ, W OBECNYM PROCESIE BRAKUJE ZROBOTYZOWANEGO SYSTEMU DLA (Polish)
    point in time
    5 July 2022
    0 references
    BIOTEHNOLOŠKO PODJETJE JE INOVATIVNA IN UČINKOVITA MONOKLONSKA PROTITELESA ZA LASTEN RAČUN IN ZA NAJEM ALI PLAČILO. ČEPRAV JE V PROTOKOLIH CEPLJENJA ZELO KONKURENČEN, SEDANJI PROCES NIMA ROBOTSKEGA SISTEMA ZA (Slovenian)
    point in time
    5 July 2022
    0 references
    BIOTECHNOLOGICKÁ SPOLEČNOST JE INOVATIVNÍ A EFEKTIVNÍ MONOKLONÁLNÍ PROTILÁTKY PRO VLASTNÍ POTŘEBU A PRO CIZÍ POTŘEBU. PŘESTOŽE JSOU V OČKOVACÍCH PROTOKOLECH VYSOCE KONKURENCESCHOPNÉ, SOUČASNÝ PROCES POSTRÁDÁ ROBOTICKÝ SYSTÉM PRO (Czech)
    point in time
    5 July 2022
    0 references
    BIOTECHNOLOGIJŲ KOMPANIJA YRA NOVATORIŠKAS IR VEIKSMINGAS MONOKLONINIAI ANTIKŪNAI SAVO SĄSKAITA IR SAMDOS PAGRINDAIS AR UŽ ATLYGĮ. NORS VAKCINACIJOS PROTOKOLAI YRA LABAI KONKURENCINGI, DABARTINIAME PROCESE TRŪKSTA ROBOTŲ SISTEMOS, SKIRTOS (Lithuanian)
    point in time
    5 July 2022
    0 references
    BIOTEHNOLOĢIJU UZŅĒMUMS IR INOVATĪVAS UN EFEKTĪVAS MONOKLONĀLĀS ANTIVIELAS UZ SAVA RĒĶINA UN PAR ATLĪDZĪBU. LAI GAN VAKCINĀCIJAS PROTOKOLOS IR ĻOTI KONKURĒTSPĒJĪGI, PAŠREIZĒJĀ PROCESĀ TRŪKST ROBOTIKAS SISTĒMAS (Latvian)
    point in time
    5 July 2022
    0 references
    БИОТЕХНОЛОГИЧНАТА КОМПАНИЯ Е ИНОВАТИВНА И ЕФЕКТИВНА МОНОКЛОНАЛНИ АНТИТЕЛА ЗА СОБСТВЕНА СМЕТКА И ЗА ЧУЖДА СМЕТКА ИЛИ СРЕЩУ ВЪЗНАГРАЖДЕНИЕ. ВЪПРЕКИ ЧЕ Е СИЛНО КОНКУРЕНТЕН ПО ОТНОШЕНИЕ НА ПРОТОКОЛИТЕ ЗА ВАКСИНАЦИЯ, В НАСТОЯЩИЯ ПРОЦЕС ЛИПСВА РОБОТИЗИРАНА СИСТЕМА ЗА (Bulgarian)
    point in time
    5 July 2022
    0 references
    A BIOTECHNOLÓGIAI VÁLLALAT INNOVATÍV ÉS HATÉKONY MONOKLONÁLIS ANTITESTEK, SAJÁT SZÁMLÁRA, BÉRLÉSRE VAGY JUTALOMRA. BÁR A VÉDŐOLTÁSI PROTOKOLLOK TERÉN RENDKÍVÜL VERSENYKÉPES, A JELENLEGI FOLYAMATBÓL HIÁNYZIK A ROBOTRENDSZER: (Hungarian)
    point in time
    5 July 2022
    0 references
    IS É AN CHUIDEACHTA BIOTECH ANTASUBSTAINTÍ MONOCLONAL NUÁLACH AGUS ÉIFEACHTACH AR A GCUNTAS FÉIN AGUS AR CÍOS NÓ AR LUAÍOCHT. CÉ GO BHFUIL AN-IOMAÍOCH I BPRÓTACAIL VACSAÍNITHE, NÍL CÓRAS RÓBATAICE SA PHRÓISEAS REATHA LE HAGHAIDH (Irish)
    point in time
    5 July 2022
    0 references
    BIOTEKNIKFÖRETAGET ÄR INNOVATIVA OCH EFFEKTIVA MONOKLONALA ANTIKROPPAR FÖR EGEN RÄKNING OCH MOT ERSÄTTNING. ÄVEN OM DEN ÄR MYCKET KONKURRENSKRAFTIG I VACCINATIONSPROTOKOLLEN SAKNAR DEN NUVARANDE PROCESSEN ETT ROBOTSYSTEM FÖR (Swedish)
    point in time
    5 July 2022
    0 references
    BIOTEHNOLOOGIA ETTEVÕTE ON UUENDUSLIK JA TÕHUS MONOKLONAALNE ANTIKEHAD ENDA ARVEL JA RENDI VÕI TASU EEST. KUIGI VAKTSINEERIMISPROTOKOLLID ON VÄGA KONKURENTSIVÕIMELISED, PUUDUB PRAEGUSEL PROTSESSIL ROBOTSÜSTEEM (Estonian)
    point in time
    5 July 2022
    0 references
    location (string)
    ROMA
    0 references
    date of last update
    8 April 2023
    0 references

    Identifiers

    Italian Unique Project Code
    F83G17000640007
    0 references
     
    Retrieved from "https://linkedopendata.eu/w/index.php?title=Item:Q2035396&oldid=42548964"